Corrigendum to “Game of clones: Battles in the field of carcinogenesis” [Pharmacology & Therapeutics, volume 237, Pages 108–251] (Pharmacology and Therapeutics (2022) 237, (S0163725822001450), (10.1016/j.pharmthera.2022.108251))

The authors sincerely regret an error that occurred in the recently published article in Pharmacology & Therapeutics (Volume 237, September 2022, 108251), titled “Game of clones: Battles in the field of carcinogenesis” (Manuscript Number: PANDT-D-22-00056R1). The error lies in section 3.4 of the article, where an incorrect citation was included in the following passage: One study showed that competition between normal pancreatic cells and those carrying the key mutation driving human pancreatic tumors, Kras^G12D, resulted in elimination of Kras^G12D cells and restoration of tissue homeostasis (Batlle & Wilkinson, 2012). The authors further pinpointed that this clearance is dependent on functional EPHA2, a receptor tyrosine kinase that regulates cell proliferation, survival, and cell-cell adhesion at tissue boundaries (Batlle & Wilkinson, 2012). In the original publication, the citation given was Batlle & Wilkinson, 2012. The authors regret this error and would like to amend this to reflect the correct citation, which is as follows: Hill W, Zaragkoulias A, Salvador-Barbero B, Parfitt GJ, Alatsatianos M, Padilha A, Porazinski S, Woolley TE, Morton JP, Sansom OJ, Hogan C. EPHA2-dependent outcompetition of KRASG12D mutant cells by wild-type neighbors in the adult pancreas. Curr Biol. 2021 Jun 21;31(12):2550–2560.e5. doi: https://doi.org/10.1016/j.cub.2021.03.094. Epub 2021 Apr 22. PMID: 33891893; PMCID: PMC8231095. The authors sincerely apologize for any confusion or misunderstanding this error may have caused to readers and appreciate the opportunity to correct the scientific record.